MAXIPHARMA A/S — Credit Rating and Financial Key Figures

MAXIPHARMA A/S (CVR number: 87375617) is a company from AARHUS. The company recorded a gross profit of 2144.7 kDKK in 2024. The operating profit was 513.8 kDKK, while net earnings were 411.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 19.3 %, which can be considered excellent but Return on Equity (ROE) was 10.6 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 81.4 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. MAXIPHARMA A/S's liquidity measured by quick ratio was 4.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.